Wyeth has two investment projects in China. Wyeth Pharmaceutical Co.Ltd., originally named Suzhou Lederle Pharmaceutical Co. Ltd., is an exclusive investment of Wyeth and was established in 1991 with a total investment of 29.9 million US dollars. Shanghai Wyeth Nutritional Co. Ltd. was founded in 1995, with a total investment of 24 million US dollars. These two investments combined total 53.9 million US dollars. Wyeth Pharmaceuticals currently has over 1,000 personnel in mainland China and Hong Kong.

Wyeth-Ayerst (China) Ltd. was founded in Delaware, America in 1992. Like Wyeth Pharmaceuticals, it is an affiliate of Wyeth. Its office in China was established in Shanghai in 1994 and mainly acts as a liaison for the importing and exporting of nutritional products and medicines produced by Wyeth and its subsidiaries.

Its Chief Representative, Dr.Wu, also acts as the President and Managing Director of Wyeth Pharmaceutical Co. Ltd. and Shanghai Wyeth Nutritional Co. Ltd. Mr. Wu and his colleagues work in the Shanghai Office, located on the 28th floor of CITIC Square at 1168, Nanjing West Rd., Shanghai. Wyeth Pharmaceutical Co. Ltd.'s factory is located at 4, Baodai West Rd., Suzhou, and Shanghai Wyeth Nutritional Co. Ltd.'s factory is located at 582, Wuzhong Rd. Shanghai.

Wyeth, Wyeth Pharmaceuticals, Wyeth Pharmaceutical Co. Ltd. and Shanghai Wyeth Nutritional Co., Ltd. will take the initiative in cooperating with the Chinese government in the implementation of its reform policies and guidelines regarding healthcare. With our strength and technical advantages, we are introducing new techniques and new products, thereby contributing to the improvement of the health and quality of life of the Chinese people.